e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Monitoring asthma: genes, cells and molecules
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LATE-BREAKING ABSTRACT: IL-5 and IL-13 are predictors of asthma remission; results from a birth cohort
D. Neville, V. Patil, L. Lau, R. Kurukulaaratchy, H. Arshad (Southampton, United Kingdom)
Source:
Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Session:
Monitoring asthma: genes, cells and molecules
Session type:
Thematic Poster Session
Number:
1106
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Neville, V. Patil, L. Lau, R. Kurukulaaratchy, H. Arshad (Southampton, United Kingdom). LATE-BREAKING ABSTRACT: IL-5 and IL-13 are predictors of asthma remission; results from a birth cohort. Eur Respir J 2013; 42: Suppl. 57, 1106
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Serum IL-5 and IL-13 consistently serve as the best predictors for the blood eosinophilia phenotype in adult asthmatics
Source: International Congress 2016 – Clinical and molecular studies in asthma
Year: 2016
TSLP as biomarker in asthma patients
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
LATE-BREAKING ABSTRACT: p-STAT6 and PU.1 are involved in IL-9 production by Th9 cells during allergen-induced late phase airway inflammation in asthma patients
Source: International Congress 2014 – Latest insights in airway diseases
Year: 2014
LATE-BREAKING ABSTRACT: A phase 2 study of benralizumab on exacerbations, lung function, and asthma control in adults with uncontrolled eosinophilic asthma
Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment
Year: 2014
LATE-BREAKING ABSTRACT: Interleukin-33 augments rhinovirus-induced type 2 immune responses in people with asthma, but not in healthy donors
Source: International Congress 2015 – Emerging strategies for airway disease treatments
Year: 2015
LATE-BREAKING ABSTRACT: TSLP as a potent activator of Th2 response in obstructive lung diseases
Source: International Congress 2016 – Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease
Year: 2016
The role of IL-13, IL-4Rα cytokine gene variants in atopic and non-atopic asthma
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
LATE-BREAKING ABSTRACT: Anti-interleukin-5 in severe asthma: Blood eosinophilia predicts lung function improvement
Source: Annual Congress 2013 –Origins and diagnosis of asthma
Year: 2013
Bronchial hyperactivity in perimenstrual asthma is higher than in non-PMA asthmatics and correlates with sputum levels of eotaxin and IL-4
Source: International Congress 2014 – Biomarkers of asthma and clinical immunology
Year: 2014
LATE-BREAKING ABSTRACT: The CCR4 Antagonist CCX6239 for the treatment of allergic airways disease
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
Levels of cytokines, sCD31 and expression of CD38 in patients with bronchial asthma of various severity out of a disease exacerbation
Source: International Congress 2014 – Biomarkers of asthma and clinical immunology
Year: 2014
The prognostic value of IFN-gamma and IL-4 cytokines ratio and CD25+ lymphocytes blood content for asthma exacerbation
Source: Annual Congress 2013 –Studies of asthma in man
Year: 2013
Correlation between asthma control and serum levels of IL-33 in atopic asthma
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016
LATE-BREAKING ABSTRACT: Disease control rate (DRC) of bronchial asthma during pregnancy
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013
QGE031 (ligelizumab) is more effective than omalizumab and placebo in inhibiting allergen-induced early asthmatic response: Results from a predictive modeling study
Source: International Congress 2015 – Asthma mechanisms and management
Year: 2015
LATE-BREAKING ABSTRACT: Serum IL-13 is a peripheral biomarker for Type 2 asthma
Source: International Congress 2015 – Emerging strategies for airway disease treatments
Year: 2015
LATE-BREAKING ABSTRACT: Mode of delivery and asthma at school age in nine European birth cohorts
Source: International Congress 2016 – Early determinants of childhood asthma and allergy
Year: 2016
Serum levels of IL-10, IL-17F, and IL-33 in asthmatic patients of south India
Source: International Congress 2014 – Biomarkers of asthma and clinical immunology
Year: 2014
Serum Th2 cytokine profiles in mould sensitised adults from a large population-based cohort
Source: International Congress 2015 – Asthma mechanisms and management
Year: 2015
Autoreactivity in patients with combined COPD and asthma phenotype
Source: International Congress 2014 – Novel approaches to human studies in allergy and asthma
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept